M

Maximus Health

Subscription-based testosterone optimization with clinicians

Head of Growth & Marketing - VP

Full-TimeUpdated on 10/23/2026
No salary listed
Expert
Remote in USA
RemoteFully remote within the United States.
Growth & MarketingGrowth Marketing

About the job

Requirements
  • Design and defend incrementality tests, measure mid-funnel and upper-funnel activity, evaluate discounts analytically, and apply experience with complex lifetime value businesses such as subscription or multi-product businesses.
  • Remain hands-on with ad accounts, funnel data, and models, with recent direct involvement.
  • Demonstrate connected-journey thinking by explaining an end-to-end funnel owned across persona, channel, creative, landing experience, and conversion.
  • Have direct ownership of post-click conversion, including landing experiences, quiz- or intake-style funnels, checkout, and lifecycle email and SMS, using structured experimentation and measurable results.
  • Have pricing and offer experience, including designing pricing, discount, or plan-structure tests and owning their revenue outcomes.
  • Have 10+ years in growth or performance marketing, including 5+ years leading teams, and a track record scaling a direct-to-consumer subscription business with a high-consideration, premium-priced product.
  • Have owned a revenue number, built a plan tying spend to revenue, and defended it to a CEO or board.
  • Have built or restructured a marketing organization, hired senior channel leads, and managed agencies to outcomes.
Responsibilities
  • Design and run a high-velocity testing program across advertising, creative, pricing, and digital product, setting hypothesis quality, test design, statistical rigor, and speed from insight to rollout.
  • Build the team's operating rhythm for planning, budgeting, creative reviews, and reporting around the experimentation cadence.
  • Own money allocation using incrementality and lifetime value rather than last-click return on ad spend; measure mid-funnel and upper-funnel activity, evaluate discounts, assess lifetime value by product and channel, and own spend, customer acquisition cost, conversion, and lifetime value levers against the forecast.
  • Own the end-to-end conversion flow through quiz and credit-card entry, including messaging continuity from ad through intake to purchase, experimentation within the flow in partnership with product and engineering, and test discipline.
  • Own pricing, price points, coupons, offers, discount architecture, and plan structure across the portfolio, including long-term commitments and margin-versus-customer-acquisition-cost tradeoffs.
  • Run email and SMS lifecycle marketing, including cart-abandonment recovery, nurture for hesitant buyers, cross-sell across the portfolio, and revival of lapsed customers, using experiments, holdouts, and measured lifetime-value impact.
  • Define channel-specific personas and use them to guide acquisition, creative, and customer journeys.
  • Own paid media, influencers, affiliates, and channel diversification; develop persona-specific creative native to each channel and judge it by funnel outcomes.
  • Lead the growth engine and set the testing agenda and standards for effective experiments.
  • Reshape the inherited team and agency roster as strategy requires, hire to fill gaps, and hold agencies accountable for outcomes.
  • Build and execute the revenue strategy across the product portfolio to achieve the company revenue target.
Desired Qualifications
  • Experience in telehealth, regulated health, or wellness, including health-claim advertising policies and compliance-constrained creative.
  • Experience marketing a multi-product portfolio with a distinct buyer for each product.

About the company

Maximus Health offers testosterone optimization for adult men experiencing low energy, motivation, and sex drive. It operates a subscription-based program built around the King Protocol, which combines prescribed testosterone-related medication with ongoing clinician support and monthly follow-ups to monitor progress. Treatments are guided by input from urology and endocrinology specialists and medical advisors to ensure safety and efficacy. The service provides continuous medical care and medication through a monthly fee, with the aim of improving energy, motivation, sexual health, and overall well-being so men can reach their full potential.

Company Size

51-200

Company Stage

Series A

Total Funding

$20M

Headquarters

Santa Monica, California

Founded

N/A

Get referred to Maximus Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Maximus raised $15 million in 2021 from Founders Fund and others.
  • Its August 2026 site still shows strong direct-pay positioning and active product breadth.
  • Men's fertility-preserving enclomiphene positioning differentiates it from standard testosterone clinics.

What critics are saying

  • FDA issued MARCS-CMS 730095 on June 8, 2026 for misleading semaglutide claims.
  • If regulators escalate to injunction or seizure, Maximus's GLP-1 revenue stalls fast.
  • Trust erodes if its homepage keeps flagged wording after the warning letter.

What makes Maximus Health unique

  • Maximus sells a men-only telehealth protocol mixing TRT, enclomiphene, and GLP-1s.
  • Its 2026 site emphasizes at-home labs, online physicians, and discreet doorstep delivery.
  • The brand pitches performance medicine, not generic hormone replacement, to ambitious adult men.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Flexible Vacation/Time-off policies
  • Remote Work Options
  • 401(k) Best-in-class options
  • 401(k) Retirement Plan
  • Full Suite: Medical, Dental, Vision, Life Insurance
  • Health Savings Account/Flexible Spending Account
  • Unlimited Paid Time Off
  • Wellness Program
  • Mental Health Support

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

33%

2 year growth

32%
The Manila Times
Apr 3rd, 2026
Maximus ranked #7 on the Financial Times' list of The Americas' Fastest Growing Companies 2026.

Maximus ranked #7 on the Financial Times' list of The Americas' Fastest Growing Companies 2026. By GlobeNewswire April 4, 2026 Santa Monica, CA, April 03, 2026 (GLOBE NEWSWIRE) - Maximus (maximustribe.com), the performance medicine telehealth company, today announced it has been named #7 on the Financial Times list of The Americas' Fastest Growing Companies 2026. This award is presented by the Financial Times and Statista Inc., a leading statistics portal and industry ranking provider. The full ranking was published today on FT.com. The Americas' Fastest Growing Companies 2026 ranking identifies the top 500 companies across North and South America that have achieved the highest compound annual growth in revenues between 2021 and 2024. Maximus's #7 placement puts it among an elite tier of the fastest-scaling businesses in the Western Hemisphere, and the second highest-ranked telehealth company on the list. Founded in 2020, Maximus is a performance medicine company that combines cutting-edge clinical science, board-certified physicians, and personalized treatment protocols-all delivered through a 100% online telehealth platform. The company originally launched with its proprietary, patented testosterone optimization protocols. Since then, Maximus has expanded into GLP-1 weight loss treatments, hair regrowth, their patent-pending Oxytocin Calming Cream, and most recently, a new generation of peptide therapies including growth hormone releasing hormones (GHRHs). This growth reflects the rapid expansion of performance medicine as a category within American healthcare. Unlike traditional sick-care models that treat symptoms reactively, performance medicine focuses on optimizing health outcomes proactively by improving hormone levels, metabolic function, and overall physical performance in people who refuse to settle for average health. The direct-to-consumer telehealth model has proven to be a powerful delivery mechanism for this category, eliminating the access barriers and long wait times that have historically kept performance-focused treatments confined to concierge medicine practices. "Being recognized as the #7 fastest growing company in the Americas is a direct reflection of the demand for what we're building," said Dr. Cameron Sepah, Founder and CEO of Maximus. "Millions of people know they can perform better-physically, mentally, and professionally-but the traditional healthcare system wasn't built to help them get there. We built Maximus to fill that gap: world-class clinical protocols, real physician oversight, and the convenience of a fully online experience. Our expansion from testosterone optimization into weight loss and now peptide therapies like GHRHs shows that when you give people access to safe, effective performance medicine, the demand is enormous." Maximus is backed by Founders Fund and 8VC, two of the most prominent venture capital firms in technology and healthcare investing. The company's sustained revenue growth from 2021 through 2024 demonstrates a durable business model built on strong client retention, expanding treatment protocols, and a growing base of clients who trust Maximus with their ongoing health optimization. Dr. Sepah added: "Our mission has always been to help people transcend their potential-to look, feel, and perform at their absolute peak. This ranking validates that the market for performance medicine is real, it's growing fast, and Maximus is leading it. We're just getting started." Statista publishes hundreds of global industry rankings and company listings in collaboration with high-profile media partners. This research and analysis service builds on the success of statista.com, a leading data and business intelligence platform providing statistics, market data, and consumer insights. About Maximus Maximus is a performance medicine telehealth company that helps people optimize their hormones, metabolism, and overall health through doctor-supervised, evidence-based protocols delivered entirely online. Founded in 2020 by Dr. Cameron Sepah, a Harvard-educated clinical psychologist and former Assistant Clinical Professor of Psychiatry at the UCSF School of Medicine, Maximus offers proprietary treatment protocols across testosterone optimization, GLP-1 weight loss, peptide therapies, and clinical-grade supplements. Every treatment plan is designed and overseen by board-certified, U.S.-based physicians. Maximus is backed by Founders Fund and 8VC. Learn more at maximustribe.com. Press Inquiries John Sheldon press [at] maximustribe.com 3415 S Sepulveda Blvd #1250 Los Angeles, CA 90034

Business Wire
Aug 10th, 2022
Maximus Raises $15M To Optimize Men’S Health Hormones Using Cutting-Edge Medicine

LOS ANGELES--(BUSINESS WIRE)--While the world is striving to solve the COVID pandemic, it is waking up to a problem that’s just as big: the hormone pandemic. Testosterone levels and sperm counts have dropped approximately 50% in the last 50 years, and a cutting-edge technology startup has risen to help men restore their vitality and masculinity. Maximus (maximustribe.com) is a Los Angeles-based consumer telemedicine company that provides at-home lab testing and doctor-prescribed protocols to optimize men’s health and hormone function, and has raised $15 million in venture financing, including its latest Series A funding round. Led by Keith Rabois at Founders Fund, other investors include 8VC, Abstract Ventures, 10X Capital, Unshackled Ventures, OneVC, Gaingels, Correlation Ventures, Chamaeleon VC, Rational Ventures, WhatIf Ventures, Shrug Capital, Electric Ant, and operators/angel investors including Dave Asprey (Bulletproof), Ryan Holiday (Daily Stoic), Brain Lee (The Honest Company), Jeff Weiser (L Catterton), Brian Nogard (ex-Tinder), Kyle Samani (Multicoin Capital), Matteo Franceschetti (Eight Sleep), & Geoffrey Wu (HVMN)